AVAmir R. Vosoughi

Amir R. Vosoughi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amir R. Vosoughi has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prevalence of phantom eye syndrome following eye removal: a systematic review and meta-analysis

    by Brendan K. Tao, Faizan Naveed, Salem A. Al-Burak, Kate Lim, Amir R. Vosoughi, Kenneth Chang, Christian El-Hadad, Georges Nassrallah, Ahsen Hussain, Bryan Arthurs, et al.

    To determine the literature-pooled prevalence of phantom eye syndrome (PES) following eye removal, including phantom vision (PV), phantom pain (PP), or phantom non-visual non-painful (PNVNP) sensations. Databases were searched from inception to March 12 2025. A systematic review and meta-analysis of PES prevalence and risk factors was conducted. Seven studies were identified (775 patients). The literature-pooled prevalence of PES, defined as having at least one constitutive symptom, was 58.9% (95% CI [50.4, 66.9], I2 = 78%, five studies). The most common constitutive symptom was PV in 35.6% (95% CI [29.5, 42.3], I2 = 71.1%, six studies), followed by PP in 26.4% (95% CI [20.8, 32.9], I2 = 76.1%, seven studies) and PNVNP in 19.9% (95% CI [7.9, 42.0], I2 = 91.2%, six studies) sensations. The pooled prevalence of reporting all three constitutive symptoms simultaneously was 4.8% (95% CI [2.2, 10.1], I2 = 67.3%, three studies). Commonly reported risk factors in the literature included mental health comorbidities and preoperative pain, though some studies did not conduct multivariable analysis to control for confounding factors. Low certainty evidence supports that over 50% of patients may develop at least one constitutive PES symptom. Patients may benefit from PES screening, reassurance, and early treatment of postoperative pain.


  • Open Access

    The use of non-person-first language in neuro-ophthalmology referrals

    by Rachel Leong, Amir R. Vosoughi, Guhan Sivakumar, Jonathan A. Micieli

  • Open Access

    The Use of Non-Person-First Language in Consecutive General Ophthalmology Referrals

    by Rachel Leong, Amir Vosoughi, Guhan Sivakumar, Jonathan A. Micieli


  • Diversity in enrollment to clinical trials for cataract medicine and surgery: meta-analysis

    by Brendan Md(C) Ka-Lok Tao, Jim Shenchu Md(C) Xie, Manvis Bsc Xia, Sahand Bmsc Marzban, Amir R. Md Vosoughi, Nina Ahuja, Guillermo Rocha

    Purpose: To investigate sex, racial, and ethnic disparities in patient enrollment across cataract trials registered in the United States. Setting: Participants enrolled in high-quality (reduced risk of bias), U.S.-registered (on ClinicalTrials.gov), cataract-related randomized controlled trials (RCTs). RCTs must be completed, have used double or greater masking, and have published results through the registry or a scholarly journal. Design: Cross-sectional database study. Methods: Trial (study sponsor country, study site location, trial initiation year, study phase, and study masking) and demographic data (sex, race, and ethnicity according to U.S. reporting guidelines) were collected. The Global Burden of Disease database provided sex-based cataract disease burdens. Pooled participation-to-prevalence ratios (PPRs) with 95% CIs were calculated for female sex, with values between 0.8 and 1.2 constituting sufficient study enrollment. Kruskal-Wallis tests (α = 0.05) with subsequent post hoc comparisons were used to evaluate demographic representations stratified by trial characteristics. Results: From 864 records, 100 clinical trials (N = 67 874) were identified, of which 97 (N = 67 697) reported sex demographics with a pooled female PPR of 0.89 (95% CI, 0.85-0.94). Of the 67 697 total participants, the absolute female enrollment was 19 062 (28.16%). Ethnicity and race were reported in 9 (N = 1792) and 26 trials (N = 23 181), respectively. Among trials that reported race, most were White (N = 19 574; 84.44%). Conclusions: High-quality, U.S.-registered, cataract trials enrolled acceptable proportions of women. However, the absolute number of female and racialized participants was low. Race and ethnicity were underreported. Disparity trends predominately held across secondary variables. To promote generalizability, future trials should pursue equitable demographic enrollment.


  • Anemia and idiopathic intracranial hypertension: a prospective study

    by Amir R. Vosoughi, Irina Sverdlichenko, Edward Margolin, Jonathan A. Micieli